Genetic diversity and protective immunity to malaria infection and disease

遗传多样性和对疟疾感染和疾病的保护性免疫力

• 批准号: 8291906
• 负责人: CHRISTOPHER V. PLOWE
• 金额: $ 59.64万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-01 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8291906
• 关键词: AS02A; Address; Africa; Alleles; Antigens; Attenuated; Award; Blood; Child; Clinical; Clinical Trials; Cohort Studies; Collaborations; Development; Disease; Epitopes; Funding; Gene Expression; Gene Proteins; Genes; Genetic; Genetic Polymorphism; Genetic Variation; Genomics; Immune response; Immune system; Immunity; Individual; Infection; Infectious Diseases Research; Instruction; International; Knowledge; Life; Malaria; Malaria Vaccines; Mali; Maryland; Measures; Membrane Proteins; Molecular; Molecular Epidemiology; Outcome; Parasites; Phase; Plasmodium falciparum; Protein Array; Proteins; Publishing; Radiation; Recombinant Proteins; Research; Research Project Grants; Research Support; Risk; Rural; Sampling; Schedule; Serological; Site; Sorting - Cell Movement; Sporozoite vaccine; Staging; Time; Translational Research; Universities; Vaccine Antigen; Vaccines; Variant; Whole Organism; acquired immunity; apical membrane; base; disorder risk; epidemiology study; experience; genome-wide; immunogenic; improved; meetings; next generation; novel; novel strategies; prevent; prospective; protective efficacy; tool; vaccine development; vaccine-induced immunity

DESCRIPTION (provided by applicant): Extreme genetic diversity in Plasmodium falciparum helps malaria parasites evade host immunity and impedes malaria vaccine development. Naturally acquired immunity to malaria is thought to represent the accumulation of protective immune responses to a repertoire of antigens and, importantly, to different variants of these antigens. But we remain largely ignorant of precisely which antigens and how many and which variants of these antigens must be recognized by which sorts of immune responses to afford natural or vaccine-induced protection. This project is largely focused on improving this understanding. Building on results of previous clinical translational research conducted in rural Mali, West Africa, we propose to further elucidate the mechanisms underlying both naturally acquired and vaccine-induced immune responses that protect against malaria infection and disease, and to use this knowledge to inform the development of broadly protective malaria vaccines. We will exploit recent technological advances to address at the genome-wide level questions that could previously be approached only one or a few genes at a time, developing new tools to assess immune responses against variant antigens and epitopes. In a prospective cohort study of children at risk for malaria infection and disease and in separate clinical trials of malaria vaccines, molecular and immunological correlates of natural and vaccine-induced protective immunity to P. falciparum infections and disease will be identified. This research is expected to provide information that will elucidate mechanisms underlying naturally acquired malaria immunity, improve the next generation of malaria vaccines and increase prospects for malaria elimination in Africa.

描述（由申请人提供）：恶性疟原虫的极端遗传多样性有助于疟原虫逃避宿主免疫，并阻碍疟疾疫苗的开发。对疟疾的天然获得性免疫被认为代表了对抗原库的保护性免疫应答的积累，重要的是，对这些抗原的不同变体的保护性免疫应答的积累。但是，我们在很大程度上仍然不知道哪些抗原、有多少抗原以及这些抗原的哪些变体必须被哪种免疫应答识别，以提供天然或疫苗诱导的保护。该项目主要侧重于提高这一认识。基于以前在西非马里农村进行的临床转化研究的结果，我们建议进一步阐明自然获得和疫苗诱导的免疫反应的机制，这些免疫反应可以防止疟疾感染和疾病，并利用这些知识来告知广泛保护性疟疾疫苗的开发。我们将利用最新的技术进步来解决全基因组水平的问题，以前只能一次处理一个或几个基因，开发新的工具来评估对变异抗原和表位的免疫反应。在一项对有疟疾感染和疾病风险的儿童进行的前瞻性队列研究中，以及在疟疾疫苗的单独临床试验中，将确定对恶性疟原虫感染和疾病的天然和疫苗诱导的保护性免疫的分子和免疫学相关性。预计这项研究将提供信息，阐明自然获得疟疾免疫力的机制，改进下一代疟疾疫苗，并增加非洲消灭疟疾的前景。